SlideShare uma empresa Scribd logo
1 de 4
The 3 Classes of Diuretics and Their Primary Sites of Action in  the Nephron For Internal Use Only Adapted from: Oparil S and Weber MA. Hypertension.Elsevier/Sanders 2nd ed. 2005; L ip G and Bakris G. Handbook Hypertension Management. CMG 2006
Thiazide Diuretics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Bendroflumethiazide 1.25-2.5 mg once daily Chlorthalidone 12.5-25 mg once daily Hydrochlorothiazide 12.5-25 mg once daily Indapamide 2.5 mg once daily or 1.5 mg  of sustained release (SR) preparation For Internal Use Only Lip G and Bakris G. Handbook Hypertension Management. CMG 2006
Loop Diuretics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Lip G and Bakris G. Handbook Hypertension Management. CMG 2006 For Internal Use Only
Diuretics that Cause Potassium Retension ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Lip G and Bakris G. Handbook Hypertension Management. CMG 2006 For Internal Use Only

Mais conteúdo relacionado

Mais procurados

Antianginal drugs.pptx
Antianginal drugs.pptxAntianginal drugs.pptx
Antianginal drugs.pptxTUSHARUNDHAD3
 
Anti hypertensive agents by Dr. Monika Singh as per PCI Syllabys 2020
Anti hypertensive agents by Dr. Monika Singh as per PCI Syllabys 2020Anti hypertensive agents by Dr. Monika Singh as per PCI Syllabys 2020
Anti hypertensive agents by Dr. Monika Singh as per PCI Syllabys 2020Monika Singh
 
Losartan drug profile
Losartan drug profile Losartan drug profile
Losartan drug profile ShahzebKhan114
 
Diuretic Drugs
Diuretic DrugsDiuretic Drugs
Diuretic DrugsEneutron
 
Class – I Antiarrhythmic Agents (Membrane Stabilizing Agent)
Class – I Antiarrhythmic Agents (Membrane Stabilizing Agent)Class – I Antiarrhythmic Agents (Membrane Stabilizing Agent)
Class – I Antiarrhythmic Agents (Membrane Stabilizing Agent)Anurag Gupta
 
34 drugs-used-in-coagulation-and-bleeding-disorders
34 drugs-used-in-coagulation-and-bleeding-disorders34 drugs-used-in-coagulation-and-bleeding-disorders
34 drugs-used-in-coagulation-and-bleeding-disordersSam Levine
 
Anti- platelet drugs
Anti- platelet drugsAnti- platelet drugs
Anti- platelet drugseducation4227
 
Drugs affecting the circulatory system
Drugs affecting the circulatory systemDrugs affecting the circulatory system
Drugs affecting the circulatory systemsharon49
 
Emergency drugs
Emergency drugsEmergency drugs
Emergency drugsSANI SINGH
 
Pharmacology of Anti platelet drugs
Pharmacology of Anti platelet drugsPharmacology of Anti platelet drugs
Pharmacology of Anti platelet drugsDr. Advaitha MV
 
Directly acting Arteriolar Dilators
Directly acting Arteriolar DilatorsDirectly acting Arteriolar Dilators
Directly acting Arteriolar DilatorsCCSU
 

Mais procurados (20)

Antianginal drugs.pptx
Antianginal drugs.pptxAntianginal drugs.pptx
Antianginal drugs.pptx
 
antihypertensive agents 1
antihypertensive agents 1antihypertensive agents 1
antihypertensive agents 1
 
Anti hypertensive agents by Dr. Monika Singh as per PCI Syllabys 2020
Anti hypertensive agents by Dr. Monika Singh as per PCI Syllabys 2020Anti hypertensive agents by Dr. Monika Singh as per PCI Syllabys 2020
Anti hypertensive agents by Dr. Monika Singh as per PCI Syllabys 2020
 
Losartan drug profile
Losartan drug profile Losartan drug profile
Losartan drug profile
 
Diuretic Drugs
Diuretic DrugsDiuretic Drugs
Diuretic Drugs
 
Class – I Antiarrhythmic Agents (Membrane Stabilizing Agent)
Class – I Antiarrhythmic Agents (Membrane Stabilizing Agent)Class – I Antiarrhythmic Agents (Membrane Stabilizing Agent)
Class – I Antiarrhythmic Agents (Membrane Stabilizing Agent)
 
antihypertensive agents 2
antihypertensive agents 2antihypertensive agents 2
antihypertensive agents 2
 
Blood pharmacology - Dental
Blood pharmacology - DentalBlood pharmacology - Dental
Blood pharmacology - Dental
 
34 drugs-used-in-coagulation-and-bleeding-disorders
34 drugs-used-in-coagulation-and-bleeding-disorders34 drugs-used-in-coagulation-and-bleeding-disorders
34 drugs-used-in-coagulation-and-bleeding-disorders
 
Anti platelet drugs
Anti platelet  drugs Anti platelet  drugs
Anti platelet drugs
 
Antiarrhythmic drug
Antiarrhythmic drugAntiarrhythmic drug
Antiarrhythmic drug
 
Anti- platelet drugs
Anti- platelet drugsAnti- platelet drugs
Anti- platelet drugs
 
Drugs affecting the circulatory system
Drugs affecting the circulatory systemDrugs affecting the circulatory system
Drugs affecting the circulatory system
 
Anticoagulants 22
Anticoagulants 22Anticoagulants 22
Anticoagulants 22
 
Warfarin
WarfarinWarfarin
Warfarin
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Emergency drugs
Emergency drugsEmergency drugs
Emergency drugs
 
Pharmacology of Anti platelet drugs
Pharmacology of Anti platelet drugsPharmacology of Anti platelet drugs
Pharmacology of Anti platelet drugs
 
Anticoagulants overdose
Anticoagulants overdoseAnticoagulants overdose
Anticoagulants overdose
 
Directly acting Arteriolar Dilators
Directly acting Arteriolar DilatorsDirectly acting Arteriolar Dilators
Directly acting Arteriolar Dilators
 

Destaque (8)

URSI 2008
URSI 2008URSI 2008
URSI 2008
 
Fármacos en cardiología ane
Fármacos en cardiología aneFármacos en cardiología ane
Fármacos en cardiología ane
 
Ciclocardiaco 22 Normal
Ciclocardiaco 22 NormalCiclocardiaco 22 Normal
Ciclocardiaco 22 Normal
 
Bloqueadores de canales de calcio
Bloqueadores de canales de calcioBloqueadores de canales de calcio
Bloqueadores de canales de calcio
 
Antagonistas Del Calcio
Antagonistas Del CalcioAntagonistas Del Calcio
Antagonistas Del Calcio
 
Beta bloqueadores
Beta bloqueadoresBeta bloqueadores
Beta bloqueadores
 
Bloqueadores de los canales de calcio
Bloqueadores de los canales de calcio Bloqueadores de los canales de calcio
Bloqueadores de los canales de calcio
 
Calcio antagonistas
Calcio antagonistasCalcio antagonistas
Calcio antagonistas
 

Semelhante a Diureticos

Antihypertensive drug part 1
Antihypertensive drug part 1 Antihypertensive drug part 1
Antihypertensive drug part 1 dr nainika sharma
 
4-171031174932.pdf
4-171031174932.pdf4-171031174932.pdf
4-171031174932.pdfBucky10
 
pharmacotherapy of hypertension
pharmacotherapy of hypertensionpharmacotherapy of hypertension
pharmacotherapy of hypertensionAdil Shah
 
HYPERTENSION - PHARMACOTHERAPY
HYPERTENSION - PHARMACOTHERAPYHYPERTENSION - PHARMACOTHERAPY
HYPERTENSION - PHARMACOTHERAPYDr.Arun Marshalin
 
Antihypertensive agents
Antihypertensive agentsAntihypertensive agents
Antihypertensive agentsSujit Karpe
 
Glimepiride Tablets USP 1mg, 2mg, 3mg, 4mg Taj Pharma PIL
Glimepiride Tablets USP 1mg, 2mg, 3mg, 4mg Taj Pharma PILGlimepiride Tablets USP 1mg, 2mg, 3mg, 4mg Taj Pharma PIL
Glimepiride Tablets USP 1mg, 2mg, 3mg, 4mg Taj Pharma PILTajPharmaQC
 
hypertensive drugs in various conditions.pptx
hypertensive drugs in various conditions.pptxhypertensive drugs in various conditions.pptx
hypertensive drugs in various conditions.pptxSunandaMohan
 
Pharmacology Talk for Med Students (1)
Pharmacology Talk for Med Students (1)Pharmacology Talk for Med Students (1)
Pharmacology Talk for Med Students (1)Richard McCrory
 
Medicinal Chemistry of Antihypertensive agents pptx
Medicinal Chemistry of Antihypertensive agents pptxMedicinal Chemistry of Antihypertensive agents pptx
Medicinal Chemistry of Antihypertensive agents pptxSameena Ramzan
 
Hypertension and treatment.pptx
Hypertension and treatment.pptxHypertension and treatment.pptx
Hypertension and treatment.pptxUrmila Aswar
 
HYPERTENSION - PHARMACOTHERAPY
HYPERTENSION - PHARMACOTHERAPYHYPERTENSION - PHARMACOTHERAPY
HYPERTENSION - PHARMACOTHERAPYDr.Arun Marshalin
 
1 Drugs for Hypertension.pptx
1 Drugs for Hypertension.pptx1 Drugs for Hypertension.pptx
1 Drugs for Hypertension.pptxSani191640
 

Semelhante a Diureticos (20)

Hypertension
HypertensionHypertension
Hypertension
 
DIURETICS.pptx
DIURETICS.pptxDIURETICS.pptx
DIURETICS.pptx
 
Antihypertensive drug part 1
Antihypertensive drug part 1 Antihypertensive drug part 1
Antihypertensive drug part 1
 
4-171031174932.pdf
4-171031174932.pdf4-171031174932.pdf
4-171031174932.pdf
 
pharmacotherapy of hypertension
pharmacotherapy of hypertensionpharmacotherapy of hypertension
pharmacotherapy of hypertension
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
AntiHypertensive Drugs
AntiHypertensive DrugsAntiHypertensive Drugs
AntiHypertensive Drugs
 
Antihypertensives - drdhriti
Antihypertensives - drdhritiAntihypertensives - drdhriti
Antihypertensives - drdhriti
 
HYPERTENSION - PHARMACOTHERAPY
HYPERTENSION - PHARMACOTHERAPYHYPERTENSION - PHARMACOTHERAPY
HYPERTENSION - PHARMACOTHERAPY
 
Antihypertensive agents
Antihypertensive agentsAntihypertensive agents
Antihypertensive agents
 
Glimepiride Tablets USP 1mg, 2mg, 3mg, 4mg Taj Pharma PIL
Glimepiride Tablets USP 1mg, 2mg, 3mg, 4mg Taj Pharma PILGlimepiride Tablets USP 1mg, 2mg, 3mg, 4mg Taj Pharma PIL
Glimepiride Tablets USP 1mg, 2mg, 3mg, 4mg Taj Pharma PIL
 
Chronic Renal Failure
Chronic Renal Failure Chronic Renal Failure
Chronic Renal Failure
 
hypertensive drugs in various conditions.pptx
hypertensive drugs in various conditions.pptxhypertensive drugs in various conditions.pptx
hypertensive drugs in various conditions.pptx
 
worlb bank
worlb bankworlb bank
worlb bank
 
Pharmacology Talk for Med Students (1)
Pharmacology Talk for Med Students (1)Pharmacology Talk for Med Students (1)
Pharmacology Talk for Med Students (1)
 
Medicinal Chemistry of Antihypertensive agents pptx
Medicinal Chemistry of Antihypertensive agents pptxMedicinal Chemistry of Antihypertensive agents pptx
Medicinal Chemistry of Antihypertensive agents pptx
 
Hypertension and treatment.pptx
Hypertension and treatment.pptxHypertension and treatment.pptx
Hypertension and treatment.pptx
 
HYPERTENSION - PHARMACOTHERAPY
HYPERTENSION - PHARMACOTHERAPYHYPERTENSION - PHARMACOTHERAPY
HYPERTENSION - PHARMACOTHERAPY
 
1 Drugs for Hypertension.pptx
1 Drugs for Hypertension.pptx1 Drugs for Hypertension.pptx
1 Drugs for Hypertension.pptx
 
Hydrochlorothiazide
HydrochlorothiazideHydrochlorothiazide
Hydrochlorothiazide
 

Mais de medicinaudm

1.6.2 Pharmacologic Treatment
1.6.2 Pharmacologic Treatment1.6.2 Pharmacologic Treatment
1.6.2 Pharmacologic Treatmentmedicinaudm
 
05 Medicina Forense
05 Medicina Forense05 Medicina Forense
05 Medicina Forensemedicinaudm
 
Clase Adrenergicos Y Bloq Adrenergicos
Clase Adrenergicos Y Bloq AdrenergicosClase Adrenergicos Y Bloq Adrenergicos
Clase Adrenergicos Y Bloq Adrenergicosmedicinaudm
 
DifusióN De Gases En El PulmóN
DifusióN De Gases En El PulmóNDifusióN De Gases En El PulmóN
DifusióN De Gases En El PulmóNmedicinaudm
 
Farmacocinetica ClíNica 07
Farmacocinetica ClíNica 07Farmacocinetica ClíNica 07
Farmacocinetica ClíNica 07medicinaudm
 
Evidencias Demencias No Alzheimer
Evidencias Demencias No AlzheimerEvidencias Demencias No Alzheimer
Evidencias Demencias No Alzheimermedicinaudm
 
Reactantes De Fase Aguda Presentacion Cristian Salinas
Reactantes De Fase Aguda Presentacion Cristian SalinasReactantes De Fase Aguda Presentacion Cristian Salinas
Reactantes De Fase Aguda Presentacion Cristian Salinasmedicinaudm
 
Sindrome De Respuesta Inflamatoria Sistemica
Sindrome De Respuesta Inflamatoria SistemicaSindrome De Respuesta Inflamatoria Sistemica
Sindrome De Respuesta Inflamatoria Sistemicamedicinaudm
 
Clase PrevenciòN Secundaria De Ave
Clase PrevenciòN Secundaria De AveClase PrevenciòN Secundaria De Ave
Clase PrevenciòN Secundaria De Avemedicinaudm
 
Ekg Alteraciones Raffo
Ekg Alteraciones RaffoEkg Alteraciones Raffo
Ekg Alteraciones Raffomedicinaudm
 
Glucocorticoides
GlucocorticoidesGlucocorticoides
Glucocorticoidesmedicinaudm
 

Mais de medicinaudm (20)

Aaaaa
AaaaaAaaaa
Aaaaa
 
Amd Turion
Amd TurionAmd Turion
Amd Turion
 
Algoritmos Acls
Algoritmos AclsAlgoritmos Acls
Algoritmos Acls
 
1.6.2 Pharmacologic Treatment
1.6.2 Pharmacologic Treatment1.6.2 Pharmacologic Treatment
1.6.2 Pharmacologic Treatment
 
05 Medicina Forense
05 Medicina Forense05 Medicina Forense
05 Medicina Forense
 
Ammenities 1
Ammenities 1Ammenities 1
Ammenities 1
 
1.6.2.7 Other
1.6.2.7 Other1.6.2.7 Other
1.6.2.7 Other
 
FcocinéTica
FcocinéTicaFcocinéTica
FcocinéTica
 
Clase Adrenergicos Y Bloq Adrenergicos
Clase Adrenergicos Y Bloq AdrenergicosClase Adrenergicos Y Bloq Adrenergicos
Clase Adrenergicos Y Bloq Adrenergicos
 
Valvulopatias
ValvulopatiasValvulopatias
Valvulopatias
 
DifusióN De Gases En El PulmóN
DifusióN De Gases En El PulmóNDifusióN De Gases En El PulmóN
DifusióN De Gases En El PulmóN
 
Farmacocinetica ClíNica 07
Farmacocinetica ClíNica 07Farmacocinetica ClíNica 07
Farmacocinetica ClíNica 07
 
Evidencias Demencias No Alzheimer
Evidencias Demencias No AlzheimerEvidencias Demencias No Alzheimer
Evidencias Demencias No Alzheimer
 
Reactantes De Fase Aguda Presentacion Cristian Salinas
Reactantes De Fase Aguda Presentacion Cristian SalinasReactantes De Fase Aguda Presentacion Cristian Salinas
Reactantes De Fase Aguda Presentacion Cristian Salinas
 
Sindrome De Respuesta Inflamatoria Sistemica
Sindrome De Respuesta Inflamatoria SistemicaSindrome De Respuesta Inflamatoria Sistemica
Sindrome De Respuesta Inflamatoria Sistemica
 
Clase PrevenciòN Secundaria De Ave
Clase PrevenciòN Secundaria De AveClase PrevenciòN Secundaria De Ave
Clase PrevenciòN Secundaria De Ave
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Dolor Cronico
Dolor CronicoDolor Cronico
Dolor Cronico
 
Ekg Alteraciones Raffo
Ekg Alteraciones RaffoEkg Alteraciones Raffo
Ekg Alteraciones Raffo
 
Glucocorticoides
GlucocorticoidesGlucocorticoides
Glucocorticoides
 

Último

How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerThousandEyes
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024The Digital Insurer
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Jeffrey Haguewood
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingEdi Saputra
 
Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)Zilliz
 
JohnPollard-hybrid-app-RailsConf2024.pptx
JohnPollard-hybrid-app-RailsConf2024.pptxJohnPollard-hybrid-app-RailsConf2024.pptx
JohnPollard-hybrid-app-RailsConf2024.pptxJohnPollard37
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodJuan lago vázquez
 
AI in Action: Real World Use Cases by Anitaraj
AI in Action: Real World Use Cases by AnitarajAI in Action: Real World Use Cases by Anitaraj
AI in Action: Real World Use Cases by AnitarajAnitaRaj43
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyKhushali Kathiriya
 
Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusZilliz
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MIND CTI
 
Platformless Horizons for Digital Adaptability
Platformless Horizons for Digital AdaptabilityPlatformless Horizons for Digital Adaptability
Platformless Horizons for Digital AdaptabilityWSO2
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native ApplicationsWSO2
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherRemote DBA Services
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...DianaGray10
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDropbox
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Orbitshub
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWERMadyBayot
 
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Victor Rentea
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc
 

Último (20)

How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)
 
JohnPollard-hybrid-app-RailsConf2024.pptx
JohnPollard-hybrid-app-RailsConf2024.pptxJohnPollard-hybrid-app-RailsConf2024.pptx
JohnPollard-hybrid-app-RailsConf2024.pptx
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
 
AI in Action: Real World Use Cases by Anitaraj
AI in Action: Real World Use Cases by AnitarajAI in Action: Real World Use Cases by Anitaraj
AI in Action: Real World Use Cases by Anitaraj
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
 
Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with Milvus
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
Platformless Horizons for Digital Adaptability
Platformless Horizons for Digital AdaptabilityPlatformless Horizons for Digital Adaptability
Platformless Horizons for Digital Adaptability
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 

Diureticos

  • 1. The 3 Classes of Diuretics and Their Primary Sites of Action in the Nephron For Internal Use Only Adapted from: Oparil S and Weber MA. Hypertension.Elsevier/Sanders 2nd ed. 2005; L ip G and Bakris G. Handbook Hypertension Management. CMG 2006
  • 2.
  • 3.
  • 4.

Notas do Editor

  1. GLB.IRB.06.12.01 Thiazide/thiazide-like diuretics : They promote diuresis by inhibiting sodium and chloride ion reabsorption at the beginning of the distal convoluted tubule . This results in an increase in excretion of sodium and chloride ions, which in turn promotes water loss. A reduction in blood volume reduces cardiac preload, cardiac output and consequently blood pressure. 2. Loop diuretics : They act on the ascending limb of Henle’s loop , increasing the excretion of sodium, potassium, calcium and chloride ions. As a result, reabsorption of water from the collecting system is virtually abolished and large volumes of water are excreted. 3. Potassium-sparing diuretics : They inhibit the exchange of sodium for potassium ions in the distal convoluted tubule of the nephron. They bring about this effect in one of two ways: * triamterene/amiloride: decreases the permeability of the distal luminal membrane to sodium ions spironolactone (aldosterone antagonist): inhibits the effects of aldosterone on the kidneys. This leads to an increased excretion of sodium ions and water, but a decreased loss of potassium ions. References: Adapted from Oparil S and Weber MA. Hypertension.Elsevier/Sanders 2nd ed. 2005 L ip G and Bakris G. Handbook Hypertension Management. CMG 2006